Compare
Abbott Laboratories vs Revvity (ABT vs RVTY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Revvity (RVTY) +67.6%; so far this year the figures are -12.3% and +60.3%.
Abbott Laboratories is the larger company by market value, about 11.0 times the size of Revvity.
On trailing earnings, ABT trades at 40.9 times and RVTY at 74.2 times.
Revenue grew +10.0% at ABT and +4.1% at RVTY over the last year.
ABT yields 2.29%. RVTY yields 0.18%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | RVTY | |
|---|---|---|
| Price | $109.93 | $155.11 |
| 1-day | -3.23% | +2.84% |
| YTD | -12.26% | +60.32% |
| 1 year | -11.73% | +67.56% |
| 3 years | +15.70% | +87.92% |
| Market cap | $190.4B | $17.3B |
| P/E | 40.9 | 74.2 |
| P/S | 3.95 | 5.94 |
| P/B | 3.73 | 2.39 |
| Revenue growth | +10.00% | +4.10% |
| EPS growth | -66.20% | -11.40% |
| Gross margin % | 56.9 | 68.3 |
| Net margin % | 9.7 | 8.2 |
| ROE % | 9.2 | 3.3 |
| Debt / equity | 0.61 | 0.44 |
| FCF yield % | 3.5 | 3.2 |
| Dividend yield % | 2.29 | 0.18 |
| Beta | 0.06 | 1.17 |
| RSI (14) | 58.5 | 50.8 |
| Technical rating |